Lab Scale Bioreactors Market size is valued at USD billion in 2021 and is expected to reach a value of USD billion by 2028, growing at a CAGR of 7.0% from 2022 to 2028. The global market provides a detailed overview of the Lab Scale Bioreactors Market, which has been segmented by product type, material type, and command type. By Product Type, the lab-scale bioreactors market has been segmented into Continuous Stirred Tank Bioreactors, Bubble Column Bioreactors, Airlift Bioreactors, Fluidized Bed Bioreactors, Packed Bed Bioreactors, and Photo-Bioreactors. The Continuous Stirred Tank Bioreactors segment is likely to be the largest and fastest-growing segment in terms of product types. By Material Type,market has been segmented into Glass, Stainless Steel, and Single-Use Plastic Polymer. The Single-Use Plastic Polymer segment is likely to be the largest and fastest-growing segment in terms of component types. Based on Command Type, the lab-scale bioreactors are segmented into Manual Control and Automated Control. According to precision business insights, the Automated Control segment is predicted to register the fastest growth rate during the forecast period.
In March 2020, Thermo Fisher Scientific Inc. acquired QIAGEN, a leading provider of life science and molecular diagnostic solutions. This acquisition allowed Thermo Fisher to leverage its industry-leading capabilities and R&D expertise to accelerate innovation and address emerging healthcare needs.